Updates coming when the trials read out.

We're tracking Okava's MEOW-1 trial (results summer 2026), Akston's Cornell trial (results mid-to-late 2026), and any FDA action on pet GLP-1. When something newsworthy happens, we'll publish here.

Updates here also draw context from the human GLP-1 space — the regulatory, clinical, and pricing patterns that shape how pet GLP-1 will reach market. The same team runs GLP-1 Picks for human telehealth, so when an FDA action, label change, or trial readout in the human space matters for pets, you'll see it here too.